Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...

Merck said on Tuesday it would not ship its ... Pfizer's bladder cancer therapy meets main goal in late-stage study Reuters, the news and media division of Thomson Reuters, is the world’s ...

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

Merck KGaA is in advanced talks to buy US cancer and rare diseases drugmaker SpringWorks Therapeutics Inc., according to a ...

British defence group Babcock on Thursday hiked its revenue expectations for the year to around 4.9 billion pounds ($6.11 billion), on the back of strength in its nuclear and marine segments.